oblimersen has been researched along with Hematologic-Diseases* in 1 studies
1 trial(s) available for oblimersen and Hematologic-Diseases
Article | Year |
---|---|
A phase I-II study of oblimersen sodium (G3139, Genasense) in combination with doxorubicin in advanced hepatocellular carcinoma (NCI # 5798).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Dose-Response Relationship, Drug; Doxorubicin; Female; Hematologic Diseases; Humans; Liver Neoplasms; Male; Middle Aged; Proto-Oncogene Proteins c-bcl-2; Thionucleotides; Treatment Outcome | 2008 |